Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P0CG29
UPID:
GST2_HUMAN
Alternative names:
GST class-theta-2
Alternative UPACC:
P0CG29; O60665; P30712; Q6IPV7; Q9HD76
Background:
Glutathione S-transferase theta-2 (GSTT2) is a crucial enzyme in the detoxification process, catalyzing the conjugation of reduced glutathione to a wide array of hydrophobic electrophiles. This process is vital for the metabolism and elimination of toxins. GSTT2 also exhibits sulfatase activity, further contributing to its role in cellular detoxification.
Therapeutic significance:
Understanding the role of Glutathione S-transferase theta-2 could open doors to potential therapeutic strategies. Its involvement in detoxification processes positions it as a key target for enhancing drug metabolism and reducing drug-induced toxicity, offering a promising avenue for the development of novel detoxification therapies.